Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors - Concepedia

Concepedia

Publication | Closed Access

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

37

Citations

22

References

2010

Year

Joleen M. Hubbard, Charles Erlichman, David O. Toft, Rui Qin, Bridget Stensgard, Sara J. Felten, Cynthia Ten Eyck, Gretchen N. Batzel, S. Percy Ivy, Paul Haluska

Investigational New Drugs

Gemcitabine And/or CisplatinMedicineCancer Management17-Allylamino-17 DemethoxygeldanamycinPathologyRefractory Solid TumorsCancer TreatmentOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1